Alaunos Therapeutics | ZIOP - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Alaunos Therapeutics USD 1.01M 175K 2026-03
Amgen USD 11.69B 6.9B 2026-06
AstraZeneca USD 12.22B 4.04B 2026-06
Baxter International USD 2.68B 3.36B 2026-06
Biogen USD 2.98B 1.02B 2026-06
Bioline Rx USD 3.48M 99K 2026-03
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Celltrion KRW 119.22B 21.46B 2026-03
Corcept Therapeutics USD 214.85M 343K 2026-06
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Curis USD 11.52M 2.5M 2026-03
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 47M 22.83M 2026-03
Divis Laboratories Ltd INR 19.51B 660M 2026-06
Gilead Sciences USD 3.95B 19.57B 2026-06
GlaxoSmithKline GBP 5.8B 468M 2026-06
Incyte USD 973.64M 4.65B 2026-06
Intrexon USD 61.56M 26.1M 2024-06
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
J&J USD 17.83B 388M 2026-06
Kangmei Pharma CNY 1.09B 304.02M 2026-03
Karyopharm Therapeutics USD 61.83M 9.9M 2026-03
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Merck USD 15.77B 2.4B 2026-06
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Novartis USD 10.2B 912M 2026-06
Organigram Holdings CAD 69.59M 14.08M 2026-03
Ovoca Bio EUR 173K 990K 2025-12
Pfizer USD 85.19B 4.91B 2026-06
Pharma Mar EUR 51.01M 8.73M 2026-06
PTC Therapeutics USD 226.66M 19.64M 2026-03
Qiagen NV USD 393.64M 17.95M 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sartorius EUR 747.8M 9.4M 2026-06
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
TG Therapeutics USD 218.66M 48.54M 2026-06
Tilray USD 237.52M 17.34M 2025-09
Verastem USD 63.57M 4.56M 2026-03
Zealand Pharma A/S 573M 202.97M 2026-03
Zz Pientze Pharmaceu CNY 1.88B 326.34M 2026-03